RxDoctor Payments Data

Randall Rodgers, DO

Family Medicine · Whitehouse, TXNPI 1104852888

Payments from drug & device makers

$3,380in general payments, 2019–2025

Across 206 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Amgen$360
  • Novartis$237
  • Daiichi Sankyo Inc.$167
  • Pfizer$161
  • Takeda Pharmaceuticals U.S.A., Inc.$156
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,34599%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,380 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$239,118
Medicare patients
229
Services billed
2,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen4,999$184,754
RelistorMethylnaltrexone Bromide47$111,209
MovantikNaloxegol Oxalate69$34,544
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen639$21,758
Lidocaine230$20,769
Gabapentin1,455$20,280
SavellaMilnacipran Hcl29$14,627
OxycontinOxycodone Hcl36$13,241
Pregabalin785$10,848
Buprenorphine38$8,961
Lidocaine-PrilocaineLidocaine/Prilocaine143$8,013
Oxycodone Hcl379$7,204
LinzessLinaclotide14$7,009
Acetaminophen-CodeineAcetaminophen With Codeine282$6,991
Morphine Sulfate220$5,930

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,210$111,20947 claims
Redhill Biopharma Inc.Movantik$64$34,54469 claims
AbbVieSavella, Linzess$133$21,63643 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$35$14,891258 claims
Almatica Pharma LLCSertraline Hcl$23$12918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Whitehouse

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →